Sparrow Pharmaceuticals Expands Clinical Trial to Treat Polymyalgia Rheumatica
By Daniella Parra Sparrow Pharmaceuticals expanded its Phase 2 clinical trial for SPI-62 in combination...
By Daniella Parra Sparrow Pharmaceuticals expanded its Phase 2 clinical trial for SPI-62 in combination...
By Tech Edge Editorial MongoDB (Nasdaq: MDB), a data platform player company, reported total revenue...
By Daniella Parra Plus Therapeutics, Inc. (Nasdaq: PSTV), a clinical-stage pharmaceutical company specializing in advanced...
By Daniella Parra Plus Therapeutics, Inc. (Nasdaq: PSTV) has expanded its partnership with Biocept with...
By Daniella Parra Eterna Therapeutics Inc. (Nasdaq: ERNA) is partnering with Lineage Cell Therapeutics, Inc....
By Karen E. Roman Octave Bioscience, Inc., a company offering treatment for multiple sclerosis and...
By Exec Edge Editorial Morrow Sodali, a global stakeholder engagement and ESG consulting firm, appointed...
By Karen E. Roman Plus Therapeutics, Inc. (Nasdaq: PSTV) announced treatment of the first patient in Part...
By Tech Edge Editorial With cyber-attacks being an inevitable occurrence for organizations, Rubrik’s solution utilizes...
By Healthcare Edge Editorial Staff Eterna Therapeutics Inc. (Nasdaq: ERNA), a life science company focused...